Greenebaum Cancer Center at University of Maryland

The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center located in Baltimore, Maryland. The center is located on the medical campus of the University of Maryland in Baltimore and is part of the university’s medical center and school of medicine.

All researchers and physicians at the center are also faculty members of the medical school and other professional schools at the University of Maryland, Baltimore. The center actively participates in new drug development and conducts pilot studies and Phase I, II, and III clinical trials.

In addition to basic and clinical cancer research, cancer center activities include teaching and a strong focus on aggressive treatment for cancer patients in the 40-bed inpatient unit, dedicated Bone Marrow/Stem Cell Transplantation unit, and 25,000-square-foot outpatient facility, which opened in 2005. The center has multidisciplinary clinical programs for all major cancers. The University of Maryland’s cancer center began as the intramural program of the National Cancer Institute (NCI) of the NIH.

In 1965, the NCI created an intramural program in the Division of Cancer Treatment (DCT) located at the U.S. Public Health Service (USPHS) Hospital in Baltimore. In 1974 the clinical unit of the BCRC moved to the University of Maryland Medical Center, and in 1976 the BCRC laboratories moved into the University of Maryland School of Medicine. In 1978, its name was changed to the Baltimore Cancer Research Program (BCRP).

In 1981 the National Cancer Institute divested the Baltimore Cancer Research Program from the federal government, and the University of Maryland School of Medicine and the Medical Center established the University of Maryland Cancer Center. In 1996, the center’s name was changed to the Marlene and Stewart Greenebaum Cancer Center (UMGCC) in recognition of a $10 million gift by its namesake benefactors: Baltimore philanthropists Marlene and Stewart Greenebaum. In 2008, it was selected to be a designated cancer center by the NCI becoming 1 of 64 centers throughout the United States to have earned that distinction.